Inhibition of amiloride-sensitive epithelial Na(+) absorption by extracellular nucleotides in human normal and cystic fibrosis airways

Am J Respir Cell Mol Biol. 2000 Dec;23(6):755-61. doi: 10.1165/ajrcmb.23.6.4207.

Abstract

Cystic fibrosis (CF) airway epithelia are characterized by enhanced Na(+) absorption probably due to a lack of downregulation of epithelial Na(+) channels by mutant CF transmembrane conductance regulator. Extracellular nucleotides adenosine 5'-triphosphate (ATP) and uridine 5'-triphosphate (UTP) have been shown to activate alternative Ca(2+)-dependent Cl(-) channels in normal and CF respiratory epithelia. Recent studies suggest additional modulation of Na(+) absorption by extracellular nucleotides. In this study we examined the role of mucosal ATP and UTP in regulating Na(+) transport in native human upper airway tissues from patients with 16 patients with CF and 32 non-CF control subjects. To that end, transepithelial voltage and equivalent short-circuit current (I(SC)) were assessed by means of a perfused micro-Ussing chamber. Mucosal ATP and UTP caused an initial increase in lumen-negative I(SC) that was followed by a sustained decrease of I(sc) in both non-CF and CF tissues. The amiloride-sensitive portion of I(SC) was inhibited significantly in normal and CF tissues in the presence of either ATP or UTP. Both basal Na(+) transport and nucleotide-dependent inhibition of amiloride-sensitive I(SC) were significantly enhanced in CF airways compared with non-CF. Nucleotide-mediated inhibition of Na(+) absorption was attenuated by pretreatment with the Ca(2+)-adenosine triphosphatase inhibitor cyclopiazonic acid but not by inhibition of protein kinase C with bisindolylmaleimide. These data demonstrate sustained inhibition of Na(+) transport in non-CF and CF airways by mucosal ATP and UTP and suggest that this effect is mediated by an increase of intracellular Ca(2+). Because ATP and UTP inhibit Na(+) absorption and stimulate Cl(-) secretion simultaneously, extracellular nucleotides could have a dual therapeutic effect, counteracting the ion transport defect in CF lung disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorption / drug effects
  • Adenosine Triphosphate / pharmacology
  • Adolescent
  • Adult
  • Aged
  • Amiloride / pharmacology*
  • Calcium / metabolism
  • Child
  • Child, Preschool
  • Cystic Fibrosis / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Epithelium / drug effects*
  • Epithelium / metabolism
  • Female
  • Humans
  • Indoles / pharmacology
  • Male
  • Maleimides / pharmacology
  • Middle Aged
  • Nasal Cavity / drug effects*
  • Nasal Cavity / metabolism
  • Nucleotides / pharmacology*
  • Protein Kinase C / antagonists & inhibitors
  • Signal Transduction
  • Sodium / pharmacokinetics*
  • Uridine Triphosphate / pharmacology

Substances

  • Enzyme Inhibitors
  • Indoles
  • Maleimides
  • Nucleotides
  • Amiloride
  • Adenosine Triphosphate
  • Sodium
  • Protein Kinase C
  • bisindolylmaleimide
  • Calcium
  • Uridine Triphosphate